• Shandong Xinhua Pharmaceutical listed eight directors and four board committees in its November 10, 2026, disclosure.
• Liu Weimin chairs the board and the strategy development committee.
• Pan Guangcheng heads the nomination committee.
• Zhu Jianwei chairs the remuneration and appraisal committee.
• Zhang Jingjing leads the audit committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Xinhua Pharmaceutical Company Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261110-12406919), on November 10, 2026, and is solely responsible for the information contained therein.